USPTO serial 90755320
HEALTHBANK
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- CHUO, EMILY M
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with HEALTHBANK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael A. Geller
Michael A. Geller DLA PIPER LLP (US)P.O. BOX 64807CHICAGO, IL 60664-0807United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | immune cells, namely, cells for scientific, laboratory or medical research; tissue cells, namely, cells for scientific, laboratory or medical research; biological tissues, namely, stem cells, progenitor cells, immune cells, tumor cells, blood-derived cells, stromal cells, connective tissue, support tissue, organ tissue, adipose and soft tissue, vascular tissue, skin and surface tissues, mucosal tissue, neural tissue, decellularized tissue, demineralized tissue, umbilical cords, placentas, bone marrow and tumor tissue for scientific, laboratory and medical research use; derivatives of the aforementioned goods, namely, proteins, peptides, enzymes, cytokines, chemokines, antibodies, DNA, RNA, growth factors, cell lysate, extracellular matrix and conditioned media for scientific, laboratory or medical research | ACTIVE | — |
| 005 | immune cells, namely, cells for medical or veterinary use; tissue cells, namely, cells for medical or veterinary use; biological tissues, namely, stem cells, progenitor cells, immune cells, tumor cells, blood-derived cells, stromal cells, connective tissue, support tissue, organ tissue, adipose and soft tissue, vascular tissue, skin and surface tissues, mucosal tissue, neural tissue, decellularized tissue, demineralized tissue, umbilical cords, placentas, bone marrow and tumor tissue for medical or veterinary use; derivatives of the aforementioned goods, namely, vaccines, proteins, peptides, cytokines, chemokines, antibodies, DNA, RNA, growth factors, cell lysate, extracellular matrix, and conditioned media for medical or veterinary use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 30, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 30, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 3, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 3, 2024 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Dec 3, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 8, 2024 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 8, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 10, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 9, 2024 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 9, 2024 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 9, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 6, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 4, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Oct 4, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Oct 4, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 19, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 17, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 17, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 17, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 16, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 14, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 14, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 14, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 24, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 29, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 29, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 9, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 22, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 22, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 22, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 22, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 22, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 21, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 26, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 8, 2021 | NWAP | NEW APPLICATION ENTERED | — |